GRCE
Grace Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Grace Therapeutics (GRCE) Stock: Buy, Sell, or Hold?
$1.81
+0.00 (+0.00%)
▲
5d:
-2.16%
30d:
-7.18%
90d:
-16.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$1.83 – $2.01
Position: OVERSOLD
Forward P/E & Valuation
-1.9x
Next 12M consensus est.
Wall Street Target
$5.85
+223.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.70 / $2.01
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: GRCE shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When GRCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GRCE is currently trading at $1.81, which is considered oversold relative to its 30-day fair value range of $1.83 to $2.01.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $2.01.
Market Sentiment: GRCE scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.85 (+223.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $2.01.
Market Sentiment: GRCE scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.85 (+223.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.83 -
$2.01
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.83 -
$2.01
Current vs Trading Range
OVERSOLD
Support Level
$1.70
Resistance Level
$2.01
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 223.3% below Wall St target ($5.85)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.90
Wall Street Target
$5.85
(+223.3%)
Share GRCE Analysis
Share this live GRCE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GRCE)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about $GRCE due to small volume, small float, high price volatility, and a successful bio fund's continued buying. No recent news articles were found.
Key Retail Themes:
Buyout speculation
Bio fund buying
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GRCE Research Pages